XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in XBiotech Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q2 2023
- Shares held
- 3.34M
- −92.4K (−2.7%) vs. Q2 2023
- Total value
- $14.0M
- −$6.41M (−31.4%) vs. Q2 2023
- New holders
- 3
- 9 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 931,444 | $3.84M | 0.00% | −28,314−3.0% | Reduced |
| Vanguard Group Inc | 872,443 | $3.59M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 278,835 | $1.15M | 0.00% | −11,012−3.8% | Reduced |
| Credit Suisse AG | 245,270 | $1.01M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 182,738 | $753.1K | 0.00% | +9,557+5.5% | Added |
| Bridgeway Capital Management, LLC | 139,241 | $573.7K | 0.01% | +12,565+9.9% | Added |
| Morgan Stanley | 87,227 | $359.4K | 0.00% | +3,331+4.0% | Added |
| Dimensional Fund Advisors LP | 72,475 | $298.4K | 0.00% | −1,839−2.5% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 64,318 | $265.0K | 0.00% | +240.0% | Added |
| State Street Corp | 56,526 | $232.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 55,693 | $229.5K | 0.00% | 00.0% | Unchanged |
| Empowered Funds, LLC | 54,200 | $223.3K | 0.01% | +4,424+8.9% | Added |
| Man Group plc | – | $222.5K | 0.00% | – | – |
| Northern Trust Corp | 52,748 | $217.3K | 0.00% | +4,788+10.0% | Added |
| Susquehanna International Group, LLP | 41,029 | $169.0K | 0.00% | +41,029 | New |
| Two Sigma Investments, LP | 30,840 | $127.1K | 0.00% | −14,200−31.5% | Reduced |
| Two Sigma Advisers, LP | 29,200 | $120.3K | 0.00% | −16,200−35.7% | Reduced |
| FMR LLC | 20,040 | $82.6K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 17,600 | $73.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 15,287 | $63.0K | 0.00% | −13,048−46.0% | Reduced |
| Bank of America Corp | 13,755 | $56.7K | 0.00% | 00.0% | Unchanged |
| Thomasville National Bank | 13,350 | $55.0K | 0.01% | 00.0% | Unchanged |
| Synovus Financial Corp | 11,796 | $48.6K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 10,822 | $44.6K | 0.00% | +1,235+12.9% | Added |
| Citadel Advisors LLC | 10,653 | $43.9K | 0.00% | −5,946−35.8% | Reduced |
| Charles Schwab Investment Management Inc | 10,477 | $43.2K | 0.00% | 00.0% | Unchanged |
| LGT Fund Management Co Ltd. | 10,000 | $38.5K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 5,277 | $21.7K | 0.00% | −813−13.3% | Reduced |
| Qube Research & Technologies Ltd | 2,560 | $10.5K | 0.00% | +2,560 | New |
| Group One Trading, L.P. | 1,738 | $7.16K | 0.00% | +1,572+947.0% | Added |
| Royal Bank of Canada | 1,435 | $6.00K | 0.00% | −1,322−48.0% | Reduced |
| McIlrath & Eck, LLC | 753 | $3.10K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 753 | $3.10K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 402 | $1.66K | 0.00% | +402 | New |
| Wells Fargo & Company | 144 | $593 | 0.00% | +17+13.4% | Added |
| Advisor Group Holdings, Inc. | 50 | $206 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 38 | $157 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 164 | $0 | 0.00% | −309−65.3% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,207−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,410−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,966−100.0% | Sold out |
| EA Series Trust | – | – | – | – | Not filed |